Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone density testing in clinical practice.

E Michael Lewiecki1, João Lindolfo C Borges

  • 1New Mexico Clinical Research and Osteoporosis Center, Albuquerque, New Mexico 87106, USA. lewiecki@aol.com

Arquivos Brasileiros De Endocrinologia E Metabologia
|November 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Consensus statement on the application of artificial intelligence in osteoporosis screening and management: perspectives from the Asia-Pacific region.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Making VFA Part of Standard Clinical DXA Assessment for Osteoporosis Care: Recommendations From the International Working Group on DXA Best Practices.

Mayo Clinic proceedings·2025
Same author

Proceedings of the 2025 Santa Fe Bone Symposium: Current concepts in the care of patients with osteoporosis, parathyroid disorders, and rare bone diseases.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2025
Same author

Effects of romosozumab and teriparatide on hip bone using 3D-SHAPER in postmenopausal women with osteoporosis.

JBMR plus·2025
Same author

Bone Health ECHO Case Report: Optimizing Bone Health in Low Fracture Risk Patient after Renal Transplant Treated with Chronic Glucocorticoids: A Case Study.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2025

Diagnosing osteoporosis and monitoring treatment presents challenges. Bone mineral density (BMD) testing, primarily using dual-energy X-ray absorptiometry (DXA), aids skeletal health assessment but requires careful interpretation for effective fracture risk management.

Area of Science:

  • Endocrinology
  • Radiology
  • Geriatrics

Background:

  • Osteoporosis diagnosis and treatment monitoring pose challenges for physicians due to numerous tests and complex interpretations.
  • Bone mineral density (BMD) testing is crucial for assessing skeletal health, with dual-energy X-ray absorptiometry (DXA) as the gold standard.
  • Despite established guidelines, many at-risk patients are undertested or undertreated for osteoporosis, including those on glucocorticoids or with existing fragility fractures.

Purpose of the Study:

  • To review the role of BMD testing in osteoporosis diagnosis and treatment monitoring.
  • To discuss the interpretation of BMD results, including T-scores and their relation to WHO classifications.
  • To highlight the need for standardized methodologies in establishing cost-effective intervention thresholds.

Related Experiment Videos

Main Methods:

  • Review of current literature and guidelines on BMD testing (DXA) for osteoporosis.
  • Analysis of fracture risk prediction using DXA and other technologies.
  • Discussion of challenges in interpreting serial BMD studies and therapy monitoring.

Main Results:

  • DXA is the gold-standard for BMD assessment, aiding in fracture risk prediction.
  • Interpretation of BMD results, including T-scores, is essential for classifying osteoporosis.
  • Optimal testing strategies and therapy monitoring require attention to calibration, technique, and precision.

Conclusions:

  • Effective osteoporosis management requires appropriate BMD testing and interpretation, despite existing challenges.
  • Standardized approaches are needed to integrate BMD with clinical risk factors for cost-effective treatment decisions.
  • Addressing undertesting and undertreatment in high-risk populations is critical for improving patient outcomes.